 MEF2 Transcription Factors
"MEF2 Transcription Factors" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Activating transcription factors of the MADS family which bind a specific sequence element (MEF2 element) in many muscle-specific genes and are involved in skeletal and cardiac myogenesis, neuronal differentiation and survival/apoptosis.
| Descriptor ID |
D064326
|
| MeSH Number(s) |
D12.776.210.500.570.294 D12.776.260.103.750.294 D12.776.260.400.249.624 D12.776.930.125.750.294 D12.776.930.397.700
|
| Concept/Terms |
MEF2 Transcription Factors- MEF2 Transcription Factors
- Transcription Factors, MEF2
- Muscle Enhancer Factor-2
- Enhancer Factor-2, Muscle
- Muscle Enhancer Factor 2
- Myocyte-Specific Enhancer-Binding Factor 2
- Myocyte Specific Enhancer Binding Factor 2
- Myocyte Enhancer Factor 2
- Myocyte-Specific Enhancer Factor 2
- Myocyte Specific Enhancer Factor 2
- MEF2 Proteins
- Muscle-Specific Enhancer Factor-2
- Enhancer Factor-2, Muscle-Specific
- Muscle Specific Enhancer Factor 2
MEF2B Transcription Factor- MEF2B Transcription Factor
- Transcription Factor, MEF2B
- Serum Response Factor-Like Protein 2
- Serum Response Factor Like Protein 2
- Myocyte-Specific Enhancer Factor 2B
- Myocyte Specific Enhancer Factor 2B
- Muscle Enhancer Factor-2B
- Enhancer Factor-2B, Muscle
- Muscle Enhancer Factor 2B
- Muscle-Specific Enhancer Factor-2B
- Enhancer Factor-2B, Muscle-Specific
- Muscle Specific Enhancer Factor 2B
- Myocyte Enhancer Factor 2B
- Myocyte-Specific Enhancer-Binding Factor 2B
- Myocyte Specific Enhancer Binding Factor 2B
- MEF2B Protein
MEF2D Transcription Factor- MEF2D Transcription Factor
- Transcription Factor, MEF2D
- Muscle Enhancer Factor-2D
- Enhancer Factor-2D, Muscle
- Muscle Enhancer Factor 2D
- Muscle-Specific Enhancer Factor-2D
- Enhancer Factor-2D, Muscle-Specific
- Muscle Specific Enhancer Factor 2D
- Myocyte-Specific Enhancer Factor 2D
- Myocyte Specific Enhancer Factor 2D
- Myocyte-Specific Enhancer-Binding Factor 2D
- Myocyte Specific Enhancer Binding Factor 2D
- MEF2D Protein
- Myocyte Enhancer Factor 2D
MEF2A Transcription Factor- MEF2A Transcription Factor
- Transcription Factor, MEF2A
- Muscle Enhancer Factor-2A
- Enhancer Factor-2A, Muscle
- Muscle Enhancer Factor 2A
- Serum Response Factor-Like Protein 1
- Serum Response Factor Like Protein 1
- Myocyte Enhancer Factor 2A
- Myocyte-Specific Enhancer Factor 2A
- Myocyte Specific Enhancer Factor 2A
- Myocyte-Specific Enhancer-Binding Factor 2A
- Myocyte Specific Enhancer Binding Factor 2A
- MEF2A Protein
- Muscle-Specific Enhancer Factor-2A
- Enhancer Factor-2A, Muscle-Specific
- Muscle Specific Enhancer Factor 2A
MEF2C Transcription Factor- MEF2C Transcription Factor
- Transcription Factor, MEF2C
- Muscle Enhancer Factor-2C
- Enhancer Factor-2C, Muscle
- Muscle Enhancer Factor 2C
- Myocyte-Specific Enhancer-Binding Factor 2C
- Myocyte Specific Enhancer Binding Factor 2C
- Myocyte Enhancer Factor 2C
- Myocyte-Specific Enhancer Factor 2C
- Myocyte Specific Enhancer Factor 2C
- MEF2C Protein
- Muscle-Specific Enhancer Factor-2C
- Enhancer Factor-2C, Muscle-Specific
- Muscle Specific Enhancer Factor 2C
|
Below are MeSH descriptors whose meaning is more general than "MEF2 Transcription Factors".
Below are MeSH descriptors whose meaning is more specific than "MEF2 Transcription Factors".
This graph shows the total number of publications written about "MEF2 Transcription Factors" by people in this website by year, and whether "MEF2 Transcription Factors" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 0 | 1 | 1 | | 1997 | 0 | 1 | 1 | | 1998 | 0 | 1 | 1 | | 1999 | 0 | 2 | 2 | | 2000 | 0 | 1 | 1 | | 2009 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "MEF2 Transcription Factors" by people in Profiles.
-
Lombardi R, Dong J, Rodriguez G, Bell A, Leung TK, Schwartz RJ, Willerson JT, Brugada R, Marian AJ. Genetic fate mapping identifies second heart field progenitor cells as a source of adipocytes in arrhythmogenic right ventricular cardiomyopathy. Circ Res. 2009 May 08; 104(9):1076-84.
-
Gajewski K, Choi CY, Kim Y, Schulz RA. Genetically distinct cardial cells within the Drosophila heart. Genesis. 2000 Sep; 28(1):36-43.
-
Schulz RA, Gajewski K. Ventral neuroblasts and the heartless FGF receptor are required for muscle founder cell specification in Drosophila. Oncogene. 1999 Nov 18; 18(48):6818-23.
-
Li X, Eastman EM, Schwartz RJ, Draghia-Akli R. Synthetic muscle promoters: activities exceeding naturally occurring regulatory sequences. Nat Biotechnol. 1999 Mar; 17(3):241-5.
-
Gajewski K, Kim Y, Choi CY, Schulz RA. Combinatorial control of Drosophila mef2 gene expression in cardiac and somatic muscle cell lineages. Dev Genes Evol. 1998 Sep; 208(7):382-92.
-
Gajewski K, Kim Y, Lee YM, Olson EN, Schulz RA. D-mef2 is a target for Tinman activation during Drosophila heart development. EMBO J. 1997 Feb 03; 16(3):515-22.
-
Croissant JD, Kim JH, Eichele G, Goering L, Lough J, Prywes R, Schwartz RJ. Avian serum response factor expression restricted primarily to muscle cell lineages is required for alpha-actin gene transcription. Dev Biol. 1996 Jul 10; 177(1):250-64.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|